MSTN and neoplasm: In line with our previous report,5 we noticed that in tumour‐bearing mice, SIRT6 over‐expression significantly downregulated expression of myostatin (MSTN), a negative regulator of muscle mass, whereas in non‐tumour‐bearing mice, no significant change was observed (Figure5A–5D).